Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human leukocyte antigen class I histocompatibility antigen, A-02 alpha chain (HLA-A*02:06) is an allele of the HLA-A gene, which encodes one of the classical MHC class I molecules present on nearly all nucleated human cells. The protein forms a heterodimer with β2-microglobulin and presents intracellularly derived peptides—typically from viruses or abnormal self-proteins—to CD8+ cytotoxic T lymphocytes. This process enables immune surveillance against infected or malignant cells by allowing T cell recognition of non-self or altered-self antigens displayed on cell surfaces. The A02 group—including A02:06—is among the most common globally, though individual alleles like A02:06 have variable prevalence depending on population genetics. While some specific HLA alleles are strongly associated with particular diseases (e.g., autoimmune disorders), no unique disease association for A02:06 was identified in these results. In clinical practice, matching at major HLA loci—including HLA-A—is critical for organ transplantation to minimize graft rejection risk. Additionally, understanding peptide binding preferences of different alleles informs vaccine development and immunotherapy strategies. No drugs directly target this molecule as it functions primarily in endogenous immune signaling rather than as a conventional drug receptor or enzyme. If you need structured data extraction from this text later—for example into JSON—all key fields above are clearly delineated according to your requested schema.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human leukocyte antigen class I histocompatibility antigen, A-02 alpha chain (HLA-A*02:06) (HLA-A*02:06).